• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.家族性间质性肺疾病风险个体的放射学异常的发展和进展。
Am J Respir Crit Care Med. 2020 May 15;201(10):1230-1239. doi: 10.1164/rccm.201909-1834OC.
2
A comparison of visual and quantitative methods to identify interstitial lung abnormalities.用于识别间质性肺异常的视觉方法与定量方法的比较。
BMC Pulm Med. 2015 Oct 29;15:134. doi: 10.1186/s12890-015-0124-x.
3
Air Pollution Exposure and Interstitial Lung Features in SPIROMICS Participants with Chronic Obstructive Pulmonary Disease.空气污染暴露与 SPIROMICS 慢性阻塞性肺疾病参与者的间质性肺特征。
Ann Am Thorac Soc. 2024 Sep;21(9):1251-1260. doi: 10.1513/AnnalsATS.202308-741OC.
4
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.影像学模式与间质性肺异常进展和死亡率相关。
Am J Respir Crit Care Med. 2019 Jul 15;200(2):175-183. doi: 10.1164/rccm.201809-1652OC.
5
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis.肺纤维化患者亲属中的间质性肺病。
Am J Respir Crit Care Med. 2020 May 15;201(10):1240-1248. doi: 10.1164/rccm.201908-1571OC.
6
Clinical Characteristics and Natural History of Autoimmune Forms of Interstitial Lung Disease: A Single-Center Experience.自身免疫性间质性肺疾病的临床特征和自然病程:一项单中心经验。
Lung. 2019 Dec;197(6):709-713. doi: 10.1007/s00408-019-00276-7. Epub 2019 Oct 3.
7
Baseline Characteristics and Progression of a Spectrum of Interstitial Lung Abnormalities and Disease in Rheumatoid Arthritis.类风湿关节炎中一系列肺间质异常和疾病的基线特征和进展。
Chest. 2020 Oct;158(4):1546-1554. doi: 10.1016/j.chest.2020.04.061. Epub 2020 May 16.
8
Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.结缔组织病相关性间质性肺炎与慢性纤维化特发性间质性肺炎的临床过程和死亡率比较。
Kaohsiung J Med Sci. 2019 Jun;35(6):365-372. doi: 10.1002/kjm2.12066. Epub 2019 Mar 26.
9
The promoter polymorphism is associated with specific interstitial lung abnormality subtypes.启动子多态性与特定的间质性肺异常亚型有关。
Eur Respir J. 2017 Sep 11;50(3). doi: 10.1183/13993003.00537-2017. Print 2017 Sep.
10
MUC5B promoter polymorphism and interstitial lung abnormalities.MUC5B 启动子多态性与肺间质异常。
N Engl J Med. 2013 Jun 6;368(23):2192-200. doi: 10.1056/NEJMoa1216076. Epub 2013 May 21.

引用本文的文献

1
Screening relatives of familial pulmonary fibrosis patients: who, when, how and why?对家族性肺纤维化患者的亲属进行筛查:对象、时间、方式及原因?
Eur Respir J. 2025 Jun 5;65(6). doi: 10.1183/13993003.00019-2025. Print 2025 Jun.
2
Approach to the Evaluation and Management of Interstitial Lung Abnormalities: An Official American Thoracic Society Clinical Statement.间质性肺异常的评估与管理方法:美国胸科学会官方临床声明
Am J Respir Crit Care Med. 2025 Jul;211(7):1132-1155. doi: 10.1164/rccm.202505-1054ST.
3
Accelerated biological ageing in familial pulmonary fibrosis.家族性肺纤维化中的生物衰老加速
Eur Respir J. 2025 Apr 3;65(4). doi: 10.1183/13993003.02427-2024. Print 2025 Apr.
4
Current perspectives on interstitial lung abnormalities.间质性肺异常的当前观点。
Korean J Intern Med. 2025 Mar;40(2):208-218. doi: 10.3904/kjim.2024.335. Epub 2025 Mar 1.
5
Protein biomarkers of interstitial lung abnormalities in relatives of patients with pulmonary fibrosis.肺纤维化患者亲属间质性肺异常的蛋白质生物标志物
Eur Respir J. 2025 Jun 5;65(6). doi: 10.1183/13993003.01349-2024. Print 2025 Jun.
6
Progressive Early Interstitial Lung Abnormalities in Persons at Risk for Familial Pulmonary Fibrosis: A Prospective Cohort Study.家族性肺纤维化高危人群的进行性早期间质性肺异常:一项前瞻性队列研究。
Am J Respir Crit Care Med. 2024 Dec 15;210(12):1441-1452. doi: 10.1164/rccm.202403-0524OC.
7
Impact of the COVID-19 Pandemic on a Program to Screen for Subclinical Familial Pulmonary Fibrosis.2019年冠状病毒病大流行对亚临床家族性肺纤维化筛查项目的影响
Am J Respir Crit Care Med. 2024 Sep 1;210(5):669-672. doi: 10.1164/rccm.202401-0034LE.
8
Scoping review of exposure questionnaires and surveys in interstitial lung disease.特发性肺纤维化(IPF)是一种慢性、进行性、纤维化性间质性肺疾病,具有高度的异质性和病死率。 2011 年美国胸科学会(ATS)和欧洲呼吸学会(ERS)联合发布的 IPF 临床诊断和治疗指南中,明确了 IPF 的诊断标准。 然而,由于 IPF 的临床表现多样,诊断较为困难,容易误诊和漏诊。 因此,对于 IPF 的高危人群,需要进行早期筛查和诊断,以提高 IPF 的早期诊断率和生存率。
BMJ Open Respir Res. 2024 May 15;11(1):e002155. doi: 10.1136/bmjresp-2023-002155.
9
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.肺纤维化的遗传学和基因组学:描绘分子图谱,塑造精准医学。
Am J Respir Crit Care Med. 2024 Aug 15;210(4):401-423. doi: 10.1164/rccm.202401-0238SO.
10
Interstitial lung abnormality evaluated by an automated quantification system: prevalence and progression rate.自动量化系统评估的间质性肺异常:患病率和进展速度。
Respir Res. 2024 Feb 6;25(1):78. doi: 10.1186/s12931-024-02715-3.

本文引用的文献

1
variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis.该变异与临床上和定量检测到的肺纤维化前病变有关。
Thorax. 2019 Dec;74(12):1131-1139. doi: 10.1136/thoraxjnl-2018-212430. Epub 2019 Sep 26.
2
Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).家族性特发性肺纤维化(f-IPF)患者的临床特征。
BMC Pulm Med. 2019 Jul 18;19(1):130. doi: 10.1186/s12890-019-0895-6.
3
Imaging Patterns Are Associated with Interstitial Lung Abnormality Progression and Mortality.影像学模式与间质性肺异常进展和死亡率相关。
Am J Respir Crit Care Med. 2019 Jul 15;200(2):175-183. doi: 10.1164/rccm.201809-1652OC.
4
Quantitative high-resolution computed tomography fibrosis score: performance characteristics in idiopathic pulmonary fibrosis.定量高分辨率计算机断层扫描纤维化评分:特发性肺纤维化中的性能特征。
Eur Respir J. 2018 Sep 17;52(3). doi: 10.1183/13993003.01384-2018. Print 2018 Sep.
5
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis.构建并验证一种用于过敏性肺炎的放射学诊断模型。
Eur Respir J. 2018 Aug 16;52(2). doi: 10.1183/13993003.00443-2018. Print 2018 Aug.
6
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.端粒酶基因中蛋白改变变异的分析及其与特发性肺纤维化患者 MUC5B 常见变异体状态的关系:候选基因测序研究。
Lancet Respir Med. 2018 Aug;6(8):603-614. doi: 10.1016/S2213-2600(18)30135-8. Epub 2018 Jun 18.
7
Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment.特发性肺纤维化发病机制、预后及治疗中的遗传学
Front Med (Lausanne). 2017 Sep 25;4:154. doi: 10.3389/fmed.2017.00154. eCollection 2017.
8
The promoter polymorphism is associated with specific interstitial lung abnormality subtypes.启动子多态性与特定的间质性肺异常亚型有关。
Eur Respir J. 2017 Sep 11;50(3). doi: 10.1183/13993003.00537-2017. Print 2017 Sep.
9
Occupational Exposures and Subclinical Interstitial Lung Disease. The MESA (Multi-Ethnic Study of Atherosclerosis) Air and Lung Studies.职业暴露与亚临床间质性肺疾病。动脉粥样硬化多民族研究(MESA)的空气与肺部研究。
Am J Respir Crit Care Med. 2017 Oct 15;196(8):1031-1039. doi: 10.1164/rccm.201612-2431OC.
10
High-Attenuation Areas on Chest Computed Tomography and Clinical Respiratory Outcomes in Community-Dwelling Adults.社区居住成年人胸部计算机断层扫描上的高衰减区域与临床呼吸结局
Am J Respir Crit Care Med. 2017 Dec 1;196(11):1434-1442. doi: 10.1164/rccm.201703-0555OC.

家族性间质性肺疾病风险个体的放射学异常的发展和进展。

Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease.

机构信息

Department of Medicine.

Department of Radiology.

出版信息

Am J Respir Crit Care Med. 2020 May 15;201(10):1230-1239. doi: 10.1164/rccm.201909-1834OC.

DOI:10.1164/rccm.201909-1834OC
PMID:32011901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7233345/
Abstract

The preclinical natural history of progressive lung fibrosis is poorly understood. Our goals were to identify risk factors for interstitial lung abnormalities (ILA) on high-resolution computed tomography (HRCT) scans and to determine progression toward clinical interstitial lung disease (ILD) among subjects in a longitudinal cohort of self-reported unaffected first-degree relatives of patients with familial interstitial pneumonia. Enrollment evaluation included a health history and exposure questionnaire and HRCT scans, which were categorized by visual assessment as no ILA, early/mild ILA, or extensive ILA. The study endpoint was met when ILA were extensive or when ILD was diagnosed clinically. Among subjects with adequate study time to complete 5-year follow-up HRCT, the proportion with ILD events (endpoint met or radiographic ILA progression) was calculated. Among 336 subjects, the mean age was 53.1 (SD, 9.9) years. Those with ILA (early/mild [ = 74] or extensive [ = 3]) were older, were more likely to be ever smokers, had shorter peripheral blood mononuclear cell telomeres, and were more likely to carry the risk allele. Self-reported occupational or environmental exposures, including aluminum smelting, lead, birds, and mold, were independently associated with ILA. Among 129 subjects with sufficient study time, 25 (19.4%) had an ILD event by 5 years after enrollment; of these, 12 met the study endpoint and another 13 had radiologic progression of ILA. ILD events were more common among those with early/mild ILA at enrollment (63.3% vs. 6.1%;  < 0.0001). Rare and common environmental exposures are independent risk factors for radiologic abnormalities. In 5 years, progression of ILA occurred in most individuals with early ILA detected at enrollment.

摘要

肺纤维化的临床前自然史知之甚少。我们的目标是确定高分辨率计算机断层扫描 (HRCT) 扫描中肺间质异常 (ILA) 的危险因素,并确定在家族性间质性肺炎患者的无影响一级亲属的纵向队列中,这些受试者向临床间质性肺病 (ILD) 的进展情况。入组评估包括病史和暴露问卷调查以及 HRCT 扫描,这些扫描通过视觉评估分为无 ILA、早期/轻度 ILA 或广泛 ILA。当 ILA 广泛或临床诊断为 ILD 时,研究终点达到。在有足够研究时间完成 5 年 HRCT 随访的受试者中,计算出ILD 事件(终点达到或影像学 ILA 进展)的比例。在 336 名受试者中,平均年龄为 53.1(标准差,9.9)岁。有 ILA(早期/轻度[=74]或广泛[=3])的受试者年龄较大,更有可能曾经吸烟,外周血单核细胞端粒较短,并且更有可能携带风险等位基因。自述职业或环境暴露,包括铝冶炼、铅、鸟类和霉菌,与 ILA 独立相关。在有足够研究时间的 129 名受试者中,有 25 名(19.4%)在入组后 5 年内发生 ILD 事件;其中 12 名达到研究终点,另有 13 名 ILA 影像学进展。在入组时患有早期 ILA 的受试者中,ILD 事件更为常见(63.3%比 6.1%;<0.0001)。罕见和常见的环境暴露是影像学异常的独立危险因素。在 5 年内,在入组时检测到早期 ILA 的大多数患者中 ILA 进展。